Skip to content
OMNIBOT MX

Randomized · Urology · 2024

Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial.

This trial offers randomized, procedure-specific feasibility evidence. Completion without conversion in this selected sample is not a system-wide success rate. Early comparisons cannot establish durable oncological or functional equivalence, and the precision of the success estimate matters as much as the absence of a statistically significant difference.

For professional education and institutional evaluation. Published research is not authorization for use in Mexico or another country. Confirm the exact device, local registration, current instructions and institutional permissions before clinical use.

Publication metadata

Original publication authors
Shaoxi Niu; Liyan Ao; Yu Gao; Fangjian Zhou; Wang He; Jin Tao; Shengjie Guo; Baojun Wang; Xing Ai; Hongzhao Li; Xin Ma; Xuepei Zhang; Jian Huang; Xu Zhang
Journal / year
European Urology Open Science; 64:2–8 · 2024
Robot model
MP1000
Verification scope
Full text and bibliographic metadata

Independent analysis

This trial offers randomized, procedure-specific feasibility evidence. Completion without conversion in this selected sample is not a system-wide success rate. Early comparisons cannot establish durable oncological or functional equivalence, and the precision of the success estimate matters as much as the absence of a statistically significant difference.

Study sample

42 patients; 21 per randomized group.

Measured outcomes

Procedures completed without conversion in 21/21 patients in each group. Median hospital stay was 7 versus 8 days (p=0.014). Postoperative complications: 4/21 versus 2/21. Operative measures, margins and early functional outcomes were also assessed.

Limitations

Small sample; three-month follow-up. The success-rate difference interval (−15.46% to +15.46%) does not establish conclusive equivalence at a 10% margin.

Source-based editorial analysis by OMNIBOT MX. No independent medical reviewer is asserted. Read the original publication and assess applicability with your institution. Publication year refers to the original research, not a fabricated date for this analysis. No medical review or review date is claimed. Published device names are preserved; commercial equivalence with OMNIBOT requires manufacturer documentation.

Reference

  1. Shaoxi Niu et al. Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial. European Urology Open Science; 64:2–8. 2024. DOI: 10.1016/j.euros.2024.02.017. Open original source

Related analyses

Request evidence documentation